Drug Patents owned by Karyopharm Theraps

1. List of Xpovio drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9714226 KARYOPHARM THERAPS Hydrazide containing nuclear transport modulators and uses thereof
Jul, 2032

(9 years from now)

US8999996 KARYOPHARM THERAPS Hydrazide containing nuclear transport modulators and uses thereof
Sep, 2032

(9 years from now)

US10519139 KARYOPHARM THERAPS Polymorphs of Selinexor
Aug, 2035

(12 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9079865 KARYOPHARM THERAPS Hydrazide containing nuclear transport modulators and uses thereof
Jul, 2032

(9 years from now)

US10544108 KARYOPHARM THERAPS Hydrazide containing nuclear transport modulators and uses thereof
Jul, 2032

(9 years from now)

US11034660 KARYOPHARM THERAPS Hydrazide containing nuclear transport modulators and uses thereof
Jul, 2032

(9 years from now)

Do you want to check out XPOVIO patents from before 2022?
Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Dec 18, 2027
New Chemical Entity Exclusivity (NCE) Jul 3, 2024
New Indication (I) Jun 22, 2023
ODE* (ODE*) Jun 22, 2027

Drugs and Companies using SELINEXOR ingredient

NCE-1 date: 2023-07-04

Market Authorisation Date: 03 July, 2019

Treatment: Xpovio is indicated in combination with dexamethasone to treat relapsed or refractory multiple myeloma (refractory to at least an anti-cd38 mab, 2 proteasome inhibitors and 2 immunomodulatory agents) ...

Dosage: TABLET;ORAL

More Information on Dosage

XPOVIO family patents

29

United States

11

Australia

8

Japan

8

China

6

Korea, Republic of

5

New Zealand

5

European Union

4

Chile

3

Colombia

EA

3

EA

3

Canada

3

Singapore

3

Ukraine

3

Hong Kong

3

Mexico

2

Denmark

2

Spain

2

Peru

2

Argentina

2

Brazil

2

South Africa

2

Hungary

2

Lithuania

1

Luxembourg

1

Israel

1

Croatia

1

Netherlands

1

ME

1

Cyprus

1

Portugal

1

Poland

1

Morocco

1

Norway

1

Slovenia

1

Georgia

1

RS

1

Taiwan

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic